Physician profile
Stephen A Erosa
NPI 1760825210
$96,301.20
in general payments reported to CMS, 2019-2025
17 companies · $45K in 2025
The $45K reported for 2025 was more than what 99% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,427 · 2020: $538 · 2021: $374 · 2022: $7,283 · 2023: $21K · 2024: $21K · 2025: $45K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $62K · Travel and Lodging: $19K · Food and Beverage: $4,873 · Education: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $62,346.04 |
| Travel and Lodging | $19,166.22 |
| Food and Beverage | $4,873.37 |
| Education | $293.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $90,185.19 | 2021-2025 | Sprint Pns System |
| Abbott Laboratories | $1,854.65 | 2019-2025 | Proclaim, Axium |
| Spinal Simplicity, LLC | $1,191.86 | 2025 | Ha Minuteman G3-R |
| Boston Scientific Corporation | $1,129.51 | 2019-2025 | Intracept |
| Bioventus LLC | $855.36 | 2019-2025 | Stimrouter Implantable Kit |
| Nevro Corp. | $224.13 | 2020-2022 | |
| Si-Bone, INC. | $166.72 | 2020-2025 | |
| Nalu Medical, INC. | $131.82 | 2024 | Nalu Neurostimulation System |
| Relievant Medsystems, INC. | $117.40 | 2023 | Intracept |
| Vertex Pharmaceuticals Incorporated | $100.30 | 2025 | |
| Medtronic, INC. | $98.83 | 2023-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Curonix LLC | $63.44 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Mml US, INC. | $50.71 | 2023 | Reactiv8 |
| Pfizer INC. | $44.38 | 2019 | |
| Globus Medical, INC. | $31.95 | 2025 | Senza |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $30.36 | 2023 | Iovera |
| Allergan, INC. | $24.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Erosa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.